home / stock / prld / prld quote
Last: | $3.62 |
---|---|
Change Percent: | 0.0% |
Open: | $3.7 |
Close: | $3.62 |
High: | $3.7 |
Low: | $3.58 |
Volume: | 10,000 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.62 | $3.7 | $3.62 | $3.7 | $3.58 | 10,000 | 07-04-2024 |
$3.62 | $3.7 | $3.62 | $3.7 | $3.58 | 10,000 | 07-03-2024 |
$3.73 | $3.8 | $3.73 | $3.8 | $3.66 | 10,241 | 07-02-2024 |
$3.77 | $3.754 | $3.77 | $3.87 | $3.625 | 36,382 | 07-01-2024 |
$3.81 | $3.71 | $3.81 | $3.88 | $3.6 | 208,471 | 06-28-2024 |
$3.69 | $3.71 | $3.69 | $3.7437 | $3.62 | 21,865 | 06-27-2024 |
$3.7 | $3.78 | $3.7 | $3.79 | $3.65 | 32,000 | 06-26-2024 |
$3.79 | $3.93 | $3.79 | $3.93 | $3.67 | 34,648 | 06-25-2024 |
$3.93 | $3.8 | $3.93 | $3.93 | $3.76 | 25,244 | 06-24-2024 |
$3.82 | $3.75 | $3.82 | $3.85 | $3.6 | 78,015 | 06-21-2024 |
$3.705 | $3.75 | $3.705 | $3.8744 | $3.6 | 87,437 | 06-20-2024 |
$3.87 | $3.78 | $3.87 | $3.95 | $3.78 | 70,877 | 06-19-2024 |
$3.87 | $3.78 | $3.87 | $3.95 | $3.78 | 70,877 | 06-18-2024 |
$3.93 | $3.88 | $3.93 | $3.95 | $3.7222 | 27,159 | 06-17-2024 |
$3.9 | $3.84 | $3.9 | $3.9079 | $3.66 | 32,316 | 06-14-2024 |
$3.9 | $4.02 | $3.9 | $4.03 | $3.86 | 27,408 | 06-13-2024 |
$4.03 | $4.19 | $4.03 | $4.44 | $3.89 | 69,567 | 06-12-2024 |
$4.02 | $3.88 | $4.02 | $4.065 | $3.85 | 46,596 | 06-11-2024 |
$3.96 | $3.59 | $3.96 | $4.015 | $3.59 | 55,274 | 06-10-2024 |
$3.75 | $3.79 | $3.75 | $3.79 | $3.635 | 17,970 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Prelude Therapeutics Incorporated Company Name:
PRLD Stock Symbol:
NASDAQ Market:
Prelude Therapeutics Incorporated Website:
2024-06-20 07:00:07 ET Peter Lawson from Barclays issued a price target of $3.00 for PRLD on 2024-06-20 05:33:00. The adjusted price target was set to $3.00. At the time of the announcement, PRLD was trading at $3.87. The overall price target consensus is at $10.67 with ...
WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June. Jefferies Global Healthcare Conference 2...
WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Life Sciences Conference, taking place in New York City on May 13 a...